Table 1.
miRNA | Action | Expression in PMOP | Sources | References |
---|---|---|---|---|
miR-9-5p | inhibit osteogenesis, promote adipogenesis promote osteoclastogenesis |
high | serum | Zhang et al. [14] Wang et al. [15] |
miR-21 | promote osteoclastogenesis promote osteogenesis and inhibit osteoclastogenesis |
unclear | Jiang et al. [16] Cheng at al. [17] Seeliger et al. [18] Yavropoulou et al. [19] Yang et al. [23] Hu et al. [24] |
|
miR-29 | unclear | low | serum | Tang et al. [1] Lian et al. [25] Kocijan et al. [26] Li et al. [27] Kapinas et al. [28] Rossi et al. [29] Bottani et al. [31] |
miR-30b-5p | negatively regulate osteoblast differentiation | low | serum | Bottani et al. [31] |
miR-31 | unclear | low | bone | Tang et a. [1] Foessl et al. [5] Mäkitie et al. [32] |
miR-100 | inhibit osteogenic differentiation | high | bone and serum | Cheng at al. [17] Seeliger et al. [18] |
miR-103-3p | inhibit osteoblast differentiation and proliferation | low | serum | Bottani et al. [31] |
miR-122-5p | inhibit osteoblast differentiation | low | serum | Mandourah et al. [33] |
miR-124 | inhibit osteoclast formation inhibit osteogenesis |
high | serum | Tang et al. [1] Yavropoulou et al. [19] Qadiret et al. [34] |
miR-133 | inhibit osteoblast differentiation increase osteoclastogenesis |
high | bone and serum (mouse) | Tang et al. [1] Cheng at al. [17] Wang et al. [35] Kocijan et al. [36] |
miR-135a-5p | inhibit osteogenic differentiation | high | bone | Shi et al. [37] |
miR-146a | inhibit osteoclastogenesis | high | bone (mouse) | Tang et al. [1] |
miR-148a | induce osteoclast formation | high | Serum (mouse) | Tang et al. [1] Xiao et al. [38] |
miR-155 | regulate osteoclastogenesis | high | unclear (mouse) | Tang et al. [1] |
miR-182-5p | inhibited ADCY6 expression and Rap1/MAPK signaling pathway activation | high | bone and serum (mouse) | Pan et al. [39] |
miR-194-5p | unclear | high | whole blood lysate | Foessl et al. [5] |
miR-200a-3p | inhibit osteogenic differentiation | high | serum | Lv et al. [40] |
miR-203a | slow osteoblast differentiation | high | bone | Kocijan et al. [36] |
miR-214-5p | promote adipogenic differentiation | high | (in vitro) | Qiu et al. [41] |
miR-221 | inhibit osteogenic inhibition | low | bone | Zhang et al. [42] |
miR-223 | inhibit osteoclast differentiation | unclear | serum | Tang et al. [1] Seeliger et al. [18] Pickering et al. [43] |
miR-338 | regulate osteoblast differentiation | high | serum | Guo et al. [44] Lin et al. [35] |
miR-365 | suppresses MMP-9 | low | bone (mouse) | Li et al. [46] |
miR-410 | regulate BMP-2 expression | high | serum | van Wijnen et al. [3] Zhang et al. [47] |
miR-422a | may stimulate osteoclastogenesis | high | human circulating monocytes | Bottani et al. [31] Cao et al. [48] |
miR-449b-5p | inhibit osteogenic differentiation | unclear | (in vivo) | Li et al. [49] |
miR-503 | inhibit osteoclast differentiation | low | human circulating monocytes | Tang et al. [1] |
miR-543 | promote osteoblast apoptosis | high | bone (mouse) | Li et al. [50] |
miR-579-3p | inhibit osteogenic differentiation | high | serum | Luo et al. [51] |
miR-874 | promote osteoblast proliferation | low | bone (mouse) | Lin et al. [52] |
miR-1297 | inhibit osteogenic differentiation | high | bone | Wang et al. [53] |
miR-2861 | promote osteoblast differentiation | high | serum | Yavropoulou et al. [19] Li et al. [54] |